BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25794249)

  • 1. Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function.
    Lê QH; El Alaoui M; Véricel E; Ségrestin B; Soulère L; Guichardant M; Lagarde M; Moulin P; Calzada C
    J Clin Endocrinol Metab; 2015 May; 100(5):2006-14. PubMed ID: 25794249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase.
    Calzada C; Coulon L; Halimi D; Le Coquil E; Pruneta-Deloche V; Moulin P; Ponsin G; Véricel E; Lagarde M
    J Clin Endocrinol Metab; 2007 May; 92(5):1961-4. PubMed ID: 17341567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia.
    Calzada C; Véricel E; Colas R; Guillot N; El Khoury G; Drai J; Sassolas A; Peretti N; Ponsin G; Lagarde M; Moulin P
    FASEB J; 2013 Jul; 27(7):2855-61. PubMed ID: 23507868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids.
    Brodde MF; Korporaal SJ; Herminghaus G; Fobker M; Van Berkel TJ; Tietge UJ; Robenek H; Van Eck M; Kehrel BE; Nofer JR
    Atherosclerosis; 2011 Apr; 215(2):374-82. PubMed ID: 21315353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
    Kuliopulos A; Mohanlal R; Covic L
    Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses.
    Garcia C; Montée N; Faccini J; Series J; Meilhac O; Cantero AV; Le Faouder P; Elbaz M; Payrastre B; Vindis C
    J Thromb Haemost; 2018 May; 16(5):933-945. PubMed ID: 29543379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of an inhibitor of diglyceride lipase on collagen-induced platelet activation.
    Jackson EC; Ortar G; McNicol A
    J Pharmacol Exp Ther; 2013 Dec; 347(3):582-8. PubMed ID: 24042163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large triglyceride-rich lipoproteins from fasting patients with type 2 diabetes activate platelets.
    Boulet MM; Cheillan D; Di Filippo M; Buisson C; Michalski MC; Moulin P; Calzada C
    Diabetes Metab; 2020 Feb; 46(1):54-60. PubMed ID: 30981822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
    Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner.
    Liou JT; Mao CC; Liu FC; Lin HT; Hung LM; Liao CH; Day YJ
    Acta Anaesthesiol Taiwan; 2012 Sep; 50(3):112-21. PubMed ID: 23026170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.
    Poeckel D; Tausch L; Altmann A; Feisst C; Klinkhardt U; Graff J; Harder S; Werz O
    Br J Pharmacol; 2005 Oct; 146(4):514-24. PubMed ID: 16086030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Wang TM; Yeung SY; Jeng PY; Liao CH; Lin TY; Lin CC; Lin BR; Jeng JH
    Atherosclerosis; 2011 Dec; 219(2):559-65. PubMed ID: 21993412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low concentrations of reactive gamma-ketoaldehydes prime thromboxane-dependent human platelet aggregation via p38-MAPK activation.
    Bernoud-Hubac N; Alam DA; Lefils J; Davies SS; Amarnath V; Guichardant M; Roberts LJ; Lagarde M
    Biochim Biophys Acta; 2009 Apr; 1791(4):307-13. PubMed ID: 19233311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase A2 activity in platelets of patients with primary thrombocythemia.
    Vecino AM; Cesar JM; Navarro JL
    Platelets; 2006 Aug; 17(5):332-5. PubMed ID: 16928606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta peptide-activated signal pathways in human platelets.
    Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
    Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of dietary linoleic acid on the platelet aggregation, fatty acid composition of platelet phospholipids and synthesis of platelet prostaglandins in rats].
    Markov KhM; Atrokhov VV; Zadkova GF; Pinelis VG; Poleshchuk VS
    Vopr Med Khim; 1988; 34(4):37-41. PubMed ID: 3195130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets.
    Colas R; Sassolas A; Guichardant M; Cugnet-Anceau C; Moret M; Moulin P; Lagarde M; Calzada C
    Diabetologia; 2011 Nov; 54(11):2931-40. PubMed ID: 21847583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.